Showing results (431-440 of 445) with videos related to
Sort By:
Pageof 45
Neuro-Oncology|October 25, 2025
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect groupNico Teske, Antonio Dono, Jacob S Young, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive GlioblastomaSara A Byron, Nhan L Tran, Rebecca F Halperin, et al.Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.Journal of Neurosurgery. Spine|October 2, 2020
Consensus-based perioperative protocols during the COVID-19 pandemicPraveen V Mummaneni, John F Burke, Andrew K Chan, et al.Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 20, 2017
The Italian Dystonia Registry: rationale, design and preliminary findingsGiovanni Defazio, M Esposito, G Abbruzzese, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 25, 2018
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findingsGiovanni Defazio, M Esposito, G Abbruzzese, et al.Neuro-Oncology|November 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responsesCalixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade GliomaShawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, et al.Pageof 45